Exchange Traded Concepts LLC Raises Position in GE HealthCare Technologies Inc. $GEHC

Exchange Traded Concepts LLC increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.7% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,340 shares of the company’s stock after purchasing an additional 1,620 shares during the quarter. Exchange Traded Concepts LLC’s holdings in GE HealthCare Technologies were worth $840,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. Hotchkis & Wiley Capital Management LLC raised its position in GE HealthCare Technologies by 3.2% in the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company’s stock worth $464,226,000 after purchasing an additional 176,572 shares during the period. JPMorgan Chase & Co. raised its position in GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after purchasing an additional 1,711,963 shares during the period. Dimensional Fund Advisors LP raised its position in GE HealthCare Technologies by 3.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company’s stock worth $398,975,000 after purchasing an additional 157,839 shares during the period. Canada Pension Plan Investment Board raised its position in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after purchasing an additional 409,636 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in GE HealthCare Technologies by 3.7% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company’s stock worth $247,708,000 after acquiring an additional 109,858 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on GEHC shares. Morgan Stanley set a $74.00 price target on shares of GE HealthCare Technologies in a report on Thursday, September 18th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday. Citigroup raised their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a report on Thursday, July 31st. BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Finally, Zacks Research raised shares of GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $88.40.

GE HealthCare Technologies Trading Down 0.2%

Shares of GEHC opened at $74.60 on Wednesday. The firm’s 50-day moving average price is $74.54 and its 200-day moving average price is $73.03. The firm has a market capitalization of $34.06 billion, a price-to-earnings ratio of 15.29, a PEG ratio of 2.86 and a beta of 1.13. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.